Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 26750-81-2
2. Cebera
3. 2-hydroxy-n-(2-hydroxyethyl)-3-methoxy-5-prop-2-enylbenzamide
4. A8co1vzk2z
5. 5-allyl-n-(2-hydroxyethyl)-3-methoxysalicylamide
6. 5-allyl-2-hydroxy-n-(2-hydroxyethyl)-3-methoxybenzamide
7. H 3774
8. Benzamide, 2-hydroxy-n-(2-hydroxyethyl)-3-methoxy-5-(2-propenyl)-
9. Ncgc00164629-01
10. H-3774
11. Dsstox_cid_26490
12. Dsstox_rid_81661
13. Dsstox_gsid_46490
14. Alibendolum
15. Alibendol [inn:dcf]
16. Alibendolum [inn-latin]
17. Einecs 247-960-9
18. Cas-26750-81-2
19. Fc 54
20. Unii-a8co1vzk2z
21. Brn 2735959
22. M-anisamide, 5-allyl-2-hydroxy-n-(2-hydroxyethyl)-
23. Alibendol [inn]
24. Alibendol [mi]
25. Hydroxy-2 Methoxy-3 Allyl-5 N-(beta-hydroxy Ethyl)benzamide [french]
26. Alibendol [mart.]
27. Alibendol [who-dd]
28. Schembl25070
29. Mls006011147
30. Chembl2105999
31. Dtxsid4046490
32. 2,6-dimethylbenzoquinone4-oxime
33. Chebi:135023
34. Benzamide, 5-allyl-2-hydroxy-n-(2-hydroxyethyl)-3-methoxy-
35. Hms3655f03
36. Hms3884i16
37. Hydroxy-2 Methoxy-3 Allyl-5 N-(beta-hydroxy Ethyl)benzamide
38. Pc-54
39. Bcp13543
40. Hy-b0326
41. Zinc1842915
42. Tox21_112247
43. 2-hydroxy-n-(2-hydroxyethyl)-3-methoxy-5-(prop-2-en-1-yl)benzamide
44. Ac-017
45. Mfcd00865165
46. S1928
47. Akos015894906
48. Tox21_112247_1
49. Ccg-266974
50. Eb 1856
51. Ncgc00164629-02
52. Ncgc00164629-03
53. As-71887
54. Smr002529526
55. Db-017556
56. Ft-0630526
57. Sw219612-1
58. H11384
59. Ab01566848_01
60. 750a812
61. Q27273767
| Molecular Weight | 251.28 g/mol |
|---|---|
| Molecular Formula | C13H17NO4 |
| XLogP3 | 1.8 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 6 |
| Exact Mass | 251.11575802 g/mol |
| Monoisotopic Mass | 251.11575802 g/mol |
| Topological Polar Surface Area | 78.8 Ų |
| Heavy Atom Count | 18 |
| Formal Charge | 0 |
| Complexity | 282 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
49
PharmaCompass offers a list of Alibendol API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Alibendol manufacturer or Alibendol supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Alibendol manufacturer or Alibendol supplier.
PharmaCompass also assists you with knowing the Alibendol API Price utilized in the formulation of products. Alibendol API Price is not always fixed or binding as the Alibendol Price is obtained through a variety of data sources. The Alibendol Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Alibendol manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Alibendol, including repackagers and relabelers. The FDA regulates Alibendol manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Alibendol API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Alibendol supplier is an individual or a company that provides Alibendol active pharmaceutical ingredient (API) or Alibendol finished formulations upon request. The Alibendol suppliers may include Alibendol API manufacturers, exporters, distributors and traders.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Alibendol Drug Master File in Korea (Alibendol KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Alibendol. The MFDS reviews the Alibendol KDMF as part of the drug registration process and uses the information provided in the Alibendol KDMF to evaluate the safety and efficacy of the drug.
After submitting a Alibendol KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Alibendol API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Alibendol suppliers with KDMF on PharmaCompass.
Alibendol Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Alibendol GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Alibendol GMP manufacturer or Alibendol GMP API supplier for your needs.
A Alibendol CoA (Certificate of Analysis) is a formal document that attests to Alibendol's compliance with Alibendol specifications and serves as a tool for batch-level quality control.
Alibendol CoA mostly includes findings from lab analyses of a specific batch. For each Alibendol CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Alibendol may be tested according to a variety of international standards, such as European Pharmacopoeia (Alibendol EP), Alibendol JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Alibendol USP).
